GrimAge2

GrimAge2 is a DNA methylation clock that estimates mortality risk, given in years. It combines age and sex with methylation-based stand-ins for smoking pack-years and nine plasma proteins, among them GDF15, cystatin C, C-reactive protein and hemoglobin A1C. Higher values go with age-related conditions such as coronary heart disease. Source: Lu et al., Aging (2022)

There are 122 papers on GrimAge2 in aging research: 5 trials and 108 observational studies in people, 3 reviews. The newest story, Nov 3, 2026: “DNA-based aging measures rose during the COVID-19 pandemic”.

Biomarker

122 papers study it3 more mention it94 findings

12 new papers in 30 daysSee all 125 papers on GrimAge2

At a glance

GrimAge2 predicts mortality in human cohorts, including people with type 2 diabetes; accelerated GrimAge2 is associated with incident frailty in Australians and higher dementia risk in women. Human trials report decreases with exercise and omega-3 fatty acids, while observational studies link smoking and social isolation with higher values.

94 findings in 61 papers from 2022 to 2026, 16 of them since May 2026

“We observed a negative correlation between the attention domain z-scores and the epigenetic aging slope for GrimAge2 (r = −0.2, P = 0.026, Figure 3A), supporting the worsening of cognition with aging acceleration.”
Exercise slows biological aging in breast cancer survivors: secondary analysis of a randomized trialJournal of the National Cancer Institute2026doi:10.1093/jnci/djag296
  • Human trial5
  • Humans108
  • In silico5

Interventions

18

Smoking cessation

downin humans3

3 studies
  1. Smoking cessation is linked with lower GrimAge2 in humans (former smokers) (β = -12.66 years; 95% CI: -14.56, -10.75).

    “Former smokers with ≥ 20 years of cessation showed a substantial reduction in GrimAge2 acceleration (β = -12.66 years; 95% CI: -14.56, -10.75)”

    Humansformer smokers

    Longer smoking cessation is linked to slower biological aging

    GeroScience

  2. Smoking cessation is linked with lower GrimAge2 in former smokers (-0.14 years).

    “However, among former smokers, each year since smoking cessation was associated with a deceleration of -0.14 (GrimAge2) and -0.06 (PhenoAge) years and -0.2% in aging pace.”

    Humansin former smokerswhole blood

    C94-01 Epigenetic Age Acceleration by Smoking: Evidence for Dose-Response and Recovery After Cessation

    American Journal of Respiratory and Critical Care Medicine

  3. Smoking cessation is linked with lower GrimAge2 in humans (former smokers, per year since cessation) (-0.14 years per year since cessation).

    “Among former smokers, each year since smoking cessation was associated with a deceleration of -0.14 (GrimAge2) and -0.06 (PhenoAge) years”

    Humansformer smokers, per year since cessationwhole blood

    Association of Smoking Behavior, Intensity, and Time Since Cessation with Epigenetic Aging Biomarkers: Results from NHANES 1999-2002

    medRxiv : the preprint server for health sciencesPreprint

More on Smoking cessation

Secondhand smoke

upin humans2

2 studies
  1. Secondhand smoke is linked with higher GrimAge2 in never and former smokers (0.8-year increase).

    “suggested a 0.8-year increase in GrimAge2 for SHS in never and former smokers.”

    Humansin never and former smokerswhole blood

    C94-01 Epigenetic Age Acceleration by Smoking: Evidence for Dose-Response and Recovery After Cessation

    American Journal of Respiratory and Critical Care Medicine

  2. Secondhand smoke is linked with higher GrimAge2 in humans (secondhand smoking) (+0.8 years).

    “suggested a 0.8-year increase in GrimAge2 with SHS exposure.”

    Humanssecondhand smokingwhole blood

    Association of Smoking Behavior, Intensity, and Time Since Cessation with Epigenetic Aging Biomarkers: Results from NHANES 1999-2002

    medRxiv : the preprint server for health sciencesPreprint

More on Secondhand smoke

Smoking

upin humans2

2 studies
  1. Smoking is linked with higher GrimAge2 in humans (compared to never smokers) (9.1 years (95% CI: 8.0, 10.2)).

    “Current and former smokers were 9.1 years (95% CI: 8.0, 10.2) and 2.8 years (95% CI: 2.3, 3.3) older in GrimAge2, respectively, compared to never smokers.”

    Humanscompared to never smokerswhole blood

    C94-01 Epigenetic Age Acceleration by Smoking: Evidence for Dose-Response and Recovery After Cessation

    American Journal of Respiratory and Critical Care Medicine

  2. Smoking is linked with higher GrimAge2 in humans (current vs never smokers) (+9.1 years (95% CI: 8.0, 10.2)).

    “GrimAge2 was 9.1 years (95% CI: 8.0, 10.2) and 2.8 years (95% CI: 2.3, 3.3) higher in current and former smokers, respectively, than in never smokers.”

    Humanscurrent vs never smokerswhole bloodn = 2,320

    Association of Smoking Behavior, Intensity, and Time Since Cessation with Epigenetic Aging Biomarkers: Results from NHANES 1999-2002

    medRxiv : the preprint server for health sciencesPreprint

More on Smoking

Elexacaftor + tezacaftor + ivacaftor

downin humans1

1 study
  1. Elexacaftor + tezacaftor + ivacaftor decreases GrimAge2 in cystic fibrosis (P=0.008).

    “DNAmGrimAge2 age acceleration decreased significantly following ETI (P=0.008; ).”

    Human trialin cystic fibrosisone-year follow-upn = 8

    Elexacaftor/tezacaftor/ivacaftor treatment is associated with epigenetic age deceleration in cystic fibrosis

    bioRxivPreprint

  2. Elexacaftor + tezacaftor + ivacaftor decreases GrimAge2 in humans (from 1.92 years to -1.70 years (p=0.008)).

    “DNAmGrimAge2 age acceleration decreased after ETI treatment, from a median of 1.92 years before treatment to -1.70 years after 1 year (p=0.008).”

    Human trial1 yearn = 8

    Elexacaftor/tezacaftor/ivacaftor treatment is associated with epigenetic age deceleration in cystic fibrosis

    bioRxivPreprint

More on Elexacaftor + tezacaftor + ivacaftor

Exercise

downin humans1

1 study
  1. Exercise decreases GrimAge2 in humans.

    “The Exercise arm showed slower epigenetic aging than the Health & Wellness arm over the 12-month study, according to GrimAge2 (P =.02) and DNAmFitAge (P =.002) clocks.”

    Human trialn = 124

    Exercise linked to slower epigenetic aging in breast cancer survivors

    Journal of the National Cancer Institute

More on Exercise

Social isolation

upin humans1

1 study
  1. Social isolation is linked with higher GrimAge2 in humans (ATE = 0.79, 95% CI = [0.26, 1.33]).

    “baseline social isolation was associated with both the second- and third-generation clocks at 10-year follow-up (e.g., GrimAge2: ATE = 0.79, 95% confidence interval [CI] = [0.26, 1.33])”

    Humans10-year follow-upn = 2,343

    Social Connection and Epigenetic Aging: Insights from DNA Methylation Clocks

    Annals of the New York Academy of Sciences

More on Social isolation

Social media use

no changein humans1

1 study
  1. Social media use was not clearly linked with GrimAge2 in humans.

    “No associations were observed with GrimAge2 across any model.”

    Humansn = 323

    Social media use duration and epigenetic aging among U.S. adults in the MIDUS refresher study

    PLOS digital health

More on Social media use

Tobacco smoking

upin humans1

1 study
  1. Tobacco smoking is linked with higher GrimAge2 in whole blood and isolated immune cell types.

    “the strongest association between DNAmAge Acceleration (DNAmAA) and smoking status was observed for the GrimAge2 model, followed by the FitAge model and then the PhenoAge model”

    Humansin whole blood and isolated immune cell types

    Smoking linked to aging measures in human immune cells

    Clinical epigenetics

More on Tobacco smoking

Healthcare access

no changein humans1

1 study
  1. Healthcare access was not clearly linked with GrimAge2 in humans (alone in models with or without insurance as a covariate).

    “Healthcare access alone did not significantly modify the associations of lead with either biomarker in models with or without insurance as a covariate.”

    Humansalone in models with or without insurance as a covariaten = 2,312

    Health insurance, healthcare access, and their roles in the association between blood lead levels and epigenetic aging in United States adults

    GeroScience

More on Healthcare access

Religiosity and spirituality

downin humans1

1 study
  1. Religiosity and spirituality is linked with lower GrimAge2 in humans (adjusted for demographic and socioeconomic characteristics).

    “all dimensions of R/S were significantly associated with slower epigenetic age acceleration as measured by GrimAge2”

    Humansadjusted for demographic and socioeconomic characteristicsn = 1,310

    Religiosity, spiritual practices, and epigenetic aging: Insights from a population-based sample of middle-aged US adults

    Psychoneuroendocrinology

More on Religiosity and spirituality

Omega-3 fatty acids

downin humans1

1 study
  1. Omega-3 fatty acids decrease GrimAge2 in humans (d = −0.32, 95% CI −0.06 to −0.59).

    “Daily omega-3 supplementation reduced the age-acceleration or pace-of-aging values of three of four clocks in our primary analysis (PhenoAge difference (d) = −0.16 (95% confidence interval (CI) −0.02 to −0.30); GrimAge2 d = −0.32 (−0.06 to −0.59); DunedinPACE d = −0.17 (−0.04 to −0.31)).”

    Human trial3 yearsn = 777

    Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial

    Nature aging

More on Omega-3 fatty acids

All 18

Effects

5

Mortality

mediatesin humans2

2 studies
  1. GrimAge2 is linked with mortality in humans (Up to 52% mediated (95% CI: 26%–128%)).

    “GrimAge2 consistently exhibited the strongest positive mediation capturing the social disparities on mortality up to 52% (95%CI: 26%-128%), followed by the DunedinPoAm.”

    HumansMediation of associations of race, ethnicity, education, income, and occupation with mortalityMortality follow-up through 2019n = 2,402

    DNA aging markers linked to social disparities in mortality

    Aging

  2. GrimAge2 is linked with mortality in humans (relationship between cadmium and mortality risk) (46.42% mediated).

    “GrimAge2-Resid, GrimAge-Resid, and DunedinPoAm accounted for 46.42 %, 43.39 %, and 21.75 % of the relationship between cadmium and mortality risk”

    Humansrelationship between cadmium and mortality risk

    Heavy metals, epigenetic aging, and mortality: A cohort study

    Ecotoxicology and environmental safety

Metabolic syndrome

mediatesin humans1upin humans1

1 study
  1. GrimAge2 is linked with metabolic syndrome in humans (1.6-3.1 % mediation proportion).

    “EAA partially mediated the association between earlier and later MetS severity (1.6-3.1 % mediation proportion, P < 0.05).”

    Humans

    Bidirectional associations between metabolic syndrome and epigenetic age acceleration: A 20-year longitudinal study in midlife adults

    Experimental gerontology

  2. GrimAge2 is linked with higher metabolic syndrome in humans (β = 0.03).

    “EAA was associated with later MetS severity (Grim2AA: β = 0.03; DunedinPACE: β = 0.01, all P < 0.05)”

    Humans10 years

    Bidirectional associations between metabolic syndrome and epigenetic age acceleration: A 20-year longitudinal study in midlife adults

    Experimental gerontology

More on Metabolic syndrome

Mild cognitive impairment

no changein humans1

1 study
  1. GrimAge2 was not clearly linked with mild cognitive impairment in humans after multiple comparison adjustment.

    “Associations between DNA methylation measures and mild cognitive impairment were not significant after multiple comparison adjustment.”

    Humansafter multiple comparison adjustmentn = 1,463

    DNA methylation age acceleration and cognitive status among older adults in the US, 1999‐2002

    AAIC 2025 abstract

More on Mild cognitive impairment

Executive function

mediatesin humans1

1 study
  1. GrimAge2 is linked with executive function in humans (vascular disease as exposure) (proportion mediated 0.20 (P = 0.002)).

    “0.20, (P = 0.002) for global cognition, episodic memory and executive function respectively”

    Humansvascular disease as exposuren = 550

    Vascular-related biological stress, DNA methylation, allostatic load and domain-specific cognition: an integrated machine learning and causal inference approach

    BMC neurology

Global cognition

mediatesin humans1

1 study
  1. GrimAge2 is linked with global cognition in humans (vascular disease as exposure) (proportion mediated 0.27 (P = 0.002)).

    “The overall proportions mediated through DNA methylation (GrimAge2) were 0.27 (P = 0.002)”

    Humansvascular disease as exposuren = 550

    Vascular-related biological stress, DNA methylation, allostatic load and domain-specific cognition: an integrated machine learning and causal inference approach

    BMC neurology

Upstream

7

Discrimination-linked negative-affect reactivity

upin humans1

1 study
  1. Discrimination-linked negative-affect reactivity is linked with higher GrimAge2 in humans (Health and Retirement Study).

    “and in the DunedinPACE and GrimAge2 clocks in the Health and Retirement Study.”

    HumansHealth and Retirement Study

    Emotional responses to discrimination linked to faster aging

    Health psychology : official journal of the Division of Health Psychology, American Psychological Association

Congenital heart disease

upin humans1

1 study
  1. Congenital heart disease is linked with higher GrimAge2 in humans (moderate congenital heart disease) (+2.1 years, P = .045).

    “GrimAge2 (+2.1 years, P = .045; +2.3 years, P = .022)”

    Humansmoderate congenital heart disease

    Accelerated epigenetic ageing in congenital heart disease: the AccelerAGE study

    European heart journal

More on Congenital heart disease

Metabolic syndrome

upin humans1

1 study
  1. Metabolic syndrome is linked with higher GrimAge2 in humans (β = 0.25).

    “earlier MetS severity was associated with EAA (Grim2AA: β = 0.25; DunedinPACE: β = 0.78, all P < 0.05)”

    Humans10 years

    Bidirectional associations between metabolic syndrome and epigenetic age acceleration: A 20-year longitudinal study in midlife adults

    Experimental gerontology

More on Metabolic syndrome

Chronic pain

upin humans1

1 study
  1. Chronic pain is linked with higher GrimAge2 in humans (without adjusting for lifestyle behaviors in PSM model) (β = 1.14, 95% CI: 0.17 to 2.10).

    “and GrimAge2 [β = 1.14, 95% CI: 0.17 to 2.10].”

    Humanswithout adjusting for lifestyle behaviors in PSM model

    The Role of Lifestyle Behaviors in Shaping the Relationship Between Chronic Pain and Epigenetic Age Acceleration: Evidence From NHANES 1998 to 2002

    Journal of pain research

More on Chronic pain

Homocysteine

upin humans1

1 study
  1. Homocysteine is linked with higher GrimAge2 in humans (1.93 y (95% CI: 1.16, 2.71)).

    “a doubling in Hcy concentration was associated with 1.05 y (0.06, 2.04) greater PhenoAge EAD, 1.93 y (1.16, 2.71) greater GrimAge2 EAD”

    Humansn = 2,346

    One-carbon metabolism-related compounds are associated with epigenetic aging biomarkers: results from the cross-sectional National Health and Nutrition Examination Survey 1999-2002

    The American journal of clinical nutrition

More on Homocysteine

Vision impairment

no changein humans1

1 study
  1. Vision impairment was not clearly linked with GrimAge2 in humans.

    “No associations were observed with self-rated vision.”

    Humansn = 2,344

    Sensory impairments and epigenetic aging: insights from self-rated hearing and vision in United States adults

    GeroScience

More on Vision impairment

Depressive symptoms

no changein humans1

1 study
  1. Depressive symptoms were not clearly linked with GrimAge2 in humans.

    “Depressive symptoms, anxiety and loneliness were not associated with GrimAge2 or DunedinPACE.”

    Humanswhole-bloodfemalesn = 32

    Sexual minority stress and epigenetic aging

    Brain, behavior, and immunity

More on Depressive symptoms

Associations

48

Mortality

upin humans5

5 studies
  1. GrimAge2 predicts mortality in type 2 diabetes mellitus (sHR 1.69 (95% CI 1.48-1.93)).

    “GrimAge2MortAcc showing the strongest predictive performance, with adjusted subdistribution hazard ratios (95% confidence interval) per standard deviation increase of 1.61 (1.39-1.87) and 1.69 (1.48-1.93)”

    Humansin type 2 diabetes mellitusn = 2,532

    Associations of DNA methylation algorithm measures of aging with type 2 diabetes and mortality risk among US older adults

    Maturitas

  2. GrimAge2 predicts mortality in humans (hazard ratio = 2.57).

    “GrimAge2 demonstrated the strongest mortality association (hazard ratio = 2.57)”

    Humans

    A unified framework for systematic curation and evaluation of aging biomarkers

    Nature aging

  3. GrimAge2 predicts mortality in humans.

    “Both were significantly associated with increased risks of death, and these associations were consistent across most subgroups.”

    Humansn = 1,942

    GrimAge and GrimAge2 Age Acceleration effectively predict mortality risk: a retrospective cohort study

    Epigenetics

  4. GrimAge2 predicts mortality in humans (meta P=3.6x10−167 versus P=2.6x10−144 for GrimAge).

    “GrimAge2 outperforms GrimAge in predicting mortality across multiple racial/ethnic groups (meta P=3.6x10−167 versus P=2.6x10−144)”

    Humansacross multiple racial/ethnic groups, after adjustment for age and sex; compared with GrimAge

    DNA methylation GrimAge version 2

    Aging

  5. GrimAge2 is associated with mortality in humans (per SD higher GrimAge2) (HR per SD: 1.65, 95% CI 1.53–1.77).

    “GrimAge2 (HR per SD: 1.65 [95% CI 1.53, 1.77] vs 1.46 [1.38, 1.55])”

    Reviewper SD higher GrimAge2

    Biological age measured by DNA methylation clocks and mortality: A systematic review and meta-analysis

    medRxivPreprint

Cognitive function

downin humans2

2 studies
  1. GrimAge2 is associated with cognitive function in humans.

    “We observed a negative correlation between the attention domain z-scores and the epigenetic aging slope for GrimAge2 (r = −0.2, P = 0.026, Figure 3A), supporting the worsening of cognition with aging acceleration.”

    Human trialn = 124

    Exercise linked to slower epigenetic aging in breast cancer survivors

    Journal of the National Cancer Institute

  2. GrimAge2 is associated with cognitive function in humans (-0.41 points (95% CI: -0.61, -0.21)).

    “One year of GrimAge2 accelerated aging was associated with -0.41 points lower DSST score (95% CI: -0.61, -0.21; adjusted p=5×10−4).”

    Humansn = 1,463

    DNA methylation age deviation and cognitive status among older adults in the US, NHANES 1999-2002

    medRxiv : the preprint server for health sciencesPreprint

IL-6

upin humans1

1 study
  1. IL-6 is associated with GrimAge2 in cystic fibrosis (FDR adjusted p < 0.05).

    “Higher IL-6, IL-1β, and calprotectin were significantly associated with greater age acceleration after FDR correction (FDR adjusted p < 0.05).”

    Human trialin cystic fibrosisone-year follow-upn = 8

    Elexacaftor/tezacaftor/ivacaftor treatment is associated with epigenetic age deceleration in cystic fibrosis

    bioRxivPreprint

  2. IL-6 is associated with GrimAge2 in humans.

    “Greater age acceleration was associated with higher IL-6, IL-1{beta}, and calprotectin concentrations.”

    Human trial

    Elexacaftor/tezacaftor/ivacaftor treatment is associated with epigenetic age deceleration in cystic fibrosis

    bioRxivPreprint

More on IL-6

Periodontitis

upin humans1OR 2.796

1 study
  1. GrimAge2 predicts periodontitis in humans (AUC = 0.700).

    “GrimAge2 demonstrated moderate discriminative ability (AUC = 0.700)”

    Humansn = 1,559

    Association between DNA methylation-based aging clocks and periodontitis in aged adults: results from NHANES 1999-2002

    Epigenomics

  2. GrimAge2 is associated with periodontitis in humans (quartile 4 vs 1) (OR 2.796, 95% CI 1.093-7.154).

    “GrimAge2 (ORquartile4vs1 = 2.796, 95% CI: 1.093-7.154)”

    Humansquartile 4 vs 1n = 1,559

    Association between DNA methylation-based aging clocks and periodontitis in aged adults: results from NHANES 1999-2002

    Epigenomics

More on Periodontitis

Left ventricular ejection fraction z-score

downin humans1

1 study
  1. GrimAge2 is associated with left ventricular ejection fraction z-score in humans (Perinatal HIV infection or exposure) (β = −0.22; 95% CI, −0.45 to 0.01).

    “GrimAge2 showed a similar direction of association (β = −0.22; 95% CI, −0.45 to 0.01).”

    HumansPerinatal HIV infection or exposuremonocyten = 123

    Epigenetic age acceleration is associated with lower left ventricular ejection fraction in young adults with perinatal HIV infection or exposure

    Clinical epigenetics

FEV1pp

downin humans1

1 study
  1. FEV1pp is associated with GrimAge2 in cystic fibrosis.

    “Higher FEV1pp was associated with lower epigenetic age acceleration, whereas higher sweat chloride concentration was associated with greater epigenetic age acceleration.”

    Human trialin cystic fibrosisone-year follow-upn = 8

    Elexacaftor/tezacaftor/ivacaftor treatment is associated with epigenetic age deceleration in cystic fibrosis

    bioRxivPreprint

Diabetes mellitus

upin humans1

1 study
  1. Diabetes mellitus is associated with GrimAge2 in humans.

    “both CVD and diabetes were associated with higher GrimAge2 and PhenoAge acceleration and a faster pace of aging at Wave 1.”

    Humansbloodfemalesn = 865

    The role of epigenetic age acceleration and social disadvantage in cardiometabolic health in southeast Louisiana women

    Clinical epigenetics

More on Diabetes mellitus

Cardiovascular disease

upin humans1

1 study
  1. Cardiovascular disease is associated with GrimAge2 in humans.

    “both CVD and diabetes were associated with higher GrimAge2 and PhenoAge acceleration and a faster pace of aging at Wave 1.”

    Humansbloodfemalesn = 865

    The role of epigenetic age acceleration and social disadvantage in cardiometabolic health in southeast Louisiana women

    Clinical epigenetics

More on Cardiovascular disease

Lead

upin humans1

1 study
  1. Lead is associated with GrimAge2 in humans.

    “insurance significantly modified associations of lead with epigenetic age.”

    Humansn = 2,312

    Health insurance, healthcare access, and their roles in the association between blood lead levels and epigenetic aging in United States adults

    GeroScience

More on Lead

Structural disadvantage

upin humans1

1 study
  1. Structural disadvantage is associated with GrimAge2 in humans (Adolescent exposure; adjusted for self-reported race and family socioeconomic status) (β 0.35 (95% CI 0.09-0.61)).

    “exposure to higher vs lower levels of structural disadvantage in adolescence was associated with accelerated epigenetic aging (GrimAge2: β, 0.35 [95% CI, 0.09-0.61];”

    HumansAdolescent exposure; adjusted for self-reported race and family socioeconomic statusvenous bloodn = 3,788

    Structural Disadvantage in Adolescence and Biological Aging in Early Midlife

    JAMA network open

More on Structural disadvantage

All 48

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    In humans, higher GrimAge2 associates with increased mortality risk. A human trial in breast cancer survivors links GrimAge2 to cognitive function and shows that exercise decreases it.

  2. Summary written from the findings.

Latest

Dec 2025: 12Jan 2026: 4Feb 2026: 2Mar 2026: 4Apr 2026: 1May 2026: 4Jun 2026: 5Jul 2026: 5Aug 2026: 5Sep 2026: 8Oct 2026: 6Nov 2026: 460 papers in 12 months
PNAS

DNA-based aging measures rose during the COVID-19 pandemic

An aging-pace measure showed an estimated rise of 0.13 on the study’s statistical scale from prepandemic levels across children, adolescents and adults.An aging-pace measure showed an estimated rise of 0.13 on the study’s statistical scale from prepandemic levels across children, adolescents and adults.

Cohort · 1,028 peoplePopulations
Clinical Epigenetics

Better heart health linked to less DNA-based age acceleration

An observational analysis of 2,401 adults aged 50 to 84 found little evidence that the links varied by race or ethnicity.An observational analysis of 2,401 adults aged 50 to 84 found little evidence that the links varied by race or ethnicity.

Cross-sectional · 2,401 peopleGrimAge
Annals of Neurology

Frontotemporal dementia linked to faster aging on a DNA clock

Patients scored 1.17 higher than controls on a blood DNA measure of accelerated aging in an adjusted analysis of two observational cohorts.Patients scored 1.17 higher than controls on a blood DNA measure of accelerated aging in an adjusted analysis of two observational cohorts.

See all 125 papers on GrimAge2